Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ibuprofen lysine versus Gelofen plus acetaminophen for post-root-canal pain in irreversible pulpitis
IRCT20140527017880N8Phase 3Completed
- Sponsor
- Kermanshah University of Medical Sciences
- Start
- Apr 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial in irreversible pulpitis comparing Ibuprofen lysine with Gelofen + acetaminophen (2 arms). Primary endpoint: pain. Started Apr 2019; status: completed.
02
Drugs
Ibuprofen L-lysineacetaminophen
03
Conditions
irreversible pulpitis
Beyond the preview
Go deeper on IRCT20140527017880N8.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20140527017880N8.